The US Food and Drug Administration (FDA) has accepted for priority review Otsuka Pharmaceutical’s new drug application (NDA) ...
The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...
Paris Hilton just highlighted her experience with it in a new interview.
Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...
Vibrant colors make food look great, but the way we get those colors is about to change. The FDA and HHS have announced a ...
A study published by the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry found that a full-spectrum ...
An updated systematic review finds exercise is as effective as therapy and medication for treating depression. Exercise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results